AI-generated summary
This review discusses photobiomodulation as a possible antioxidant approach after myocardial infarction. The authors report that preclinical studies consistently show reduced infarct size and improved heart function, and that clinical evidence is limited, showing possibly modest improvements. They note that variable protocols and study designs prevent definitive conclusions about clinical efficacy.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The authors state that clinical evidence is still limited and that variability in treatment protocols, delivery methods and study designs precludes definitive conclusions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on physoc.onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Reactive oxygen species, Oxidative stress, Cytochrome c oxidase, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.